TITLE

Pleural Effusion and Breast Cancer

AUTHOR(S)
Stoll, Basil A.
PUB. DATE
March 1965
SOURCE
British Medical Journal;3/6/1965, Vol. 1 Issue 5435, p658
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64057967

 

Related Articles

  • Catumaxomab.  // Reactions Weekly;1/28/2012, Issue 1386, p14 

    The article describes the case of a 53-year-old woman with breast cancer and a 68-year-old man with lung cancer who developed various toxicities following two doses of catumaxomab for malignant pleural effusion.

  • Malignant Pleural Effusion. Shuey, Kathleen; Payne, Yvette; Burke, Catherine // Clinical Journal of Oncology Nursing;Oct2005, Vol. 9 Issue 5, p529 

    Provides information on malignant pleural effusion (MPE), a disease caused by direct tumor involvement of the pleural space by solid or hematologic malignancies. Types of cancer associated with 75 percent of MPE; Symptoms associated with pleural effusion; Diagnosis and treatment.

  • Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis. Miyoshi, Shion; Sasada, Shinji; Izumo, Takehiro; Matsumoto, Yuji; Tsuchida, Takaaki // PLoS ONE;11/23/2016, Vol. 11 Issue 11, p1 

    Background: Some trials recently demonstrated the benefit of targeted treatment for malignant disease; therefore, adequate tissues are needed to detect the targeted gene. Pleural biopsy using flex-rigid pleuroscopy and pleural effusion cell block analysis are both useful for diagnosis of...

  • Fatores clínicos e anatomopatológicos que influenciam a sobrevida de pacientes com câncer de mama e derrame pleural neoplásico. Tavares dos Santos, Giovana; Carlos Prolla, João; Dressler Camillo, Natália; Silveira Zavalhia, Lisiane; Ranzi, Alana Durayski; Giuliano Bica, Claudia // Jornal Brasileiro de Pneumologia;jul/aug2012, Vol. 38 Issue 4, p487 

    Objective: The objective of this study was to identify the clinical and pathological factors that can influence the prognosis of breast cancer patients with clinical symptoms of malignant pleural effusion. Methods: This was a clinical cohort study, in which we analyzed the medical charts of...

  • Primary Effusion Lymphoma In A Non-HIV Patient: A Case Report And Discussion Of Treatment Modalities. Heidecker, Jay T.; Strange, Charlie // Internet Journal of Pulmonary Medicine;2004, Vol. 4 Issue 2, p29 

    Pleural effusion is a rare initial presentation of lymphoma. There is a subset of lymphoma based in serosal surfaces that is almost universally associated with advanced HIV infection. We describe a case of primary pleural SCLL that proved refractory to pleuridesis. With initiation of...

  • Use of the Pleurx® Pleural Catheter for the Management of Malignant Pleural Effusions. Brubacher, Sara; Gobel, Barbara Holmes // Clinical Journal of Oncology Nursing;Jan/Feb2003, Vol. 7 Issue 1, p1 

    Many patients with cancer, especially those with lung and breast cancer, experience malignant pleural effusions. Several treatment options exist, and most require hospitalization. The Pleurx® Pleural Catheter (Denver Biomedical, Golden, CO) is a new treatment option that allows patients to be...

  • Purified talc.  // Reactions Weekly;1/31/2009, Issue 1237, p20 

    The article describes the case of a 39-year-old woman who developed interstitial pneumonitis with respiratory failure following talc pleurodesis. The patient, who had a history of breast cancer, underwent talc pleurodesis for a recurrent, symptomatic left pleural effusion. Time to reaction onset...

  • Effect of IL-6 Elevation in Malignant Pleural Effusion on Hyperfibrinogenemia in Lung Cancer Patients. Yamaguchi, Toshihiko; Kimura, Hiromi; Yokota, Soichiro; Yamamoto, Yuko; Hashimoto, Taikichi; Nakagawa, Masaru; Ito, Masami; Ogura, Takeshi // Japanese Journal of Clinical Oncology;Feb2000, Vol. 30 Issue 2 

    Investigates the effect of interleukin-6 (IL-6) elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients. Measurements of IL-6 and tumor necrosis factor-alpha in serum and pleural effusion; Immunohistochemical detection of IL-6 in pleural cells; Systemic leakage of...

  • Clinico- pathological profile and course of malignant pleural effusion in a tertiary care teaching hospital in western U.P. with special reference to lung cancer. Agrawal, Anurag; Tandon, Rajeev; Singh, Lalit; Chawla, Aakanksha // Lung India;Jul/Aug2015, Vol. 32 Issue 4, p326 

    Background: Malignant pleural effusion is a major clinical problem associated with primary and metastatic pleural malignancies. Pleural effusions from an unknown primary are responsible for 7-15% of all malignant pleural effusions. Presence of malignant pleural effusion puts the patient in...

  • MCF-7 Cells--Changing the Course of Breast Cancer Research and Care for 45 Years. Lee, Adrian V.; Oesterreich, Stefi; Davidson, Nancy E. // JNCI: Journal of the National Cancer Institute;7/15/2015, Vol. 107 Issue 7, p1 

    It is 45 years since a pleural effusion from a patient with metastatic breast cancer led to the generation of the MCF-7 breast cancer cell line. MCF-7 is the most studied human breast cancer cell line in the world, and results from this cell line have had a fundamental impact upon breast cancer...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics